🎁 Black Friday: up to 50% off of annual plans
Ono Pharmaceutical Co., Ltd. (TYO:4528)
Japan flag Japan · Delayed Price · Currency is JPY
2,460.00
-44.00 (-1.76%)
Nov 20, 2026, 3:30 PM JST

Ono Pharmaceutical Income Statement

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
491,153515,785486,871502,672447,187361,361
Revenue Growth
-2.48%5.94%-3.14%12.41%23.75%16.84%
Cost of Revenue
127,170141,716147,950127,126110,06293,511
Gross Profit
363,983374,069338,921375,546337,125267,850
Selling, General & Admin
107,349120,596122,21997,38986,64374,119
Research & Development
145,115147,043149,866112,17495,34475,879
Other Operating Expenses
5,6926,4411,5922,8072,2504,099
Operating Expenses
261,251277,175277,129215,251187,080157,035
Operating Income
102,73296,89461,792160,295150,045110,815
Interest Expense
-2,204-2,212-1,450-125-89-84
Interest & Investment Income
3,8553,4584,6313,5742,4032,349
Earnings From Equity Investments
--12514-6
Currency Exchange Gain (Loss)
-313-313-1,861347-723-425
Other Non Operating Income (Expenses)
31831821235182399
EBT Excluding Unusual Items
104,38898,14563,258164,327151,822113,048
Gain (Loss) on Sale of Investments
-632-632-1,730-92-46-116
Gain (Loss) on Sale of Assets
-4,598-4,598-214-118-94-64
Asset Writedown
-261-261-1,981-51-498-316
Legal Settlements
---4-333-7,652-7,527
Pretax Income
98,89792,65459,329163,733143,532105,025
Income Tax Expense
23,93622,7439,16335,69430,61924,340
Earnings From Continuing Operations
74,96169,91150,166128,039112,91380,685
Minority Interest in Earnings
-353-144-119-62-190-166
Net Income
74,60869,76750,047127,977112,72380,519
Net Income to Common
74,60869,76750,047127,977112,72380,519
Net Income Growth
53.85%39.40%-60.89%13.53%40.00%6.75%
Shares Outstanding (Basic)
470470470480488496
Shares Outstanding (Diluted)
470470470480488497
Shares Change
0.09%0.04%-2.14%-1.70%-1.65%-0.54%
EPS (Basic)
158.76148.49106.55266.61230.85162.19
EPS (Diluted)
158.64148.42106.41266.57230.79162.16
EPS Growth
53.88%39.48%-60.08%15.50%42.32%7.33%

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
127,189130,79777,028106,640154,27056,332
Free Cash Flow Per Share
270.44278.31163.97222.15315.90113.45
Dividend Per Share
40.00080.00080.00080.00070.00056.000
Dividend Growth
-50.00%0%0%14.29%25.00%12.00%
Gross Margin
74.11%72.52%69.61%74.71%75.39%74.12%
Operating Margin
20.92%18.79%12.69%31.89%33.55%30.67%
Profit Margin
15.19%13.53%10.28%25.46%25.21%22.28%
Free Cash Flow Margin
25.90%25.36%15.82%21.21%34.50%15.59%
EBITDA
139,987134,64688,686178,435167,496128,536
EBITDA Margin
28.50%26.11%18.22%35.50%37.45%35.57%
D&A For EBITDA
37,25537,75226,89418,14017,45117,721
EBIT
102,73296,89461,792160,295150,045110,815
EBIT Margin
20.92%18.79%12.69%31.89%33.55%30.67%
Effective Tax Rate
24.20%24.55%15.44%21.80%21.33%23.18%
Advertising Expenses
-32,17730,65124,01917,83711,496